CENIT AG (CSH.DE) Stock Fundamental Analysis

FRA:CSH • DE0005407100

6.6 EUR
0 (0%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall CSH gets a fundamental rating of 3 out of 10. We evaluated CSH against 117 industry peers in the Software industry. Both the profitability and financial health of CSH have multiple concerns. CSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CSH had negative earnings in the past year.
  • In the past year CSH had a positive cash flow from operations.
  • Of the past 5 years CSH 4 years were profitable.
  • In the past 5 years CSH always reported a positive cash flow from operatings.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

  • CSH has a worse Return On Assets (-3.14%) than 64.96% of its industry peers.
  • CSH's Return On Equity of -12.50% is on the low side compared to the rest of the industry. CSH is outperformed by 69.23% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.04%, CSH is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • CSH had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 13.32%.
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROIC 1.04%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • The Operating Margin of CSH (0.91%) is comparable to the rest of the industry.
  • CSH's Operating Margin has declined in the last couple of years.
  • CSH has a Gross Margin of 60.04%. This is in the lower half of the industry: CSH underperforms 64.10% of its industry peers.
  • CSH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.91%
PM (TTM) N/A
GM 60.04%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CSH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CSH remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CSH remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for CSH is higher compared to a year ago.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • CSH has an Altman-Z score of 2.13. This is not the best score and indicates that CSH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.13, CSH is in line with its industry, outperforming 47.01% of the companies in the same industry.
  • CSH has a debt to FCF ratio of 4.02. This is a neutral value as CSH would need 4.02 years to pay back of all of its debts.
  • CSH has a Debt to FCF ratio (4.02) which is in line with its industry peers.
  • CSH has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • CSH has a Debt to Equity ratio of 1.10. This is amonst the worse of the industry: CSH underperforms 82.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Altman-Z 2.13
ROIC/WACC0.15
WACC6.89%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

  • CSH has a Current Ratio of 1.27. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.27, CSH perfoms like the industry average, outperforming 41.88% of the companies in the same industry.
  • CSH has a Quick Ratio of 1.27. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
  • CSH has a Quick ratio of 1.27. This is comparable to the rest of the industry: CSH outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -252.87%.
  • CSH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.58%.
  • Measured over the past years, CSH shows a small growth in Revenue. The Revenue has been growing by 3.84% on average per year.
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%

3.2 Future

  • Based on estimates for the next years, CSH will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.23% on average per year.
  • The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 46.68, which means the current valuation is very expensive for CSH.
  • CSH's Price/Forward Earnings is on the same level as the industry average.
  • CSH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.98.
Industry RankSector Rank
PE N/A
Fwd PE 46.68
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • 88.89% of the companies in the same industry are more expensive than CSH, based on the Enterprise Value to EBITDA ratio.
  • 96.58% of the companies in the same industry are more expensive than CSH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.85
EV/EBITDA 6.45
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • CSH's earnings are expected to grow with 16.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.3%
EPS Next 3Y16.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.15%, CSH is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.69, CSH pays a better dividend. On top of this CSH pays more dividend than 95.73% of the companies listed in the same industry.
  • CSH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

  • The dividend of CSH decreases each year by -41.82%.
Dividend Growth(5Y)-41.82%
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

More info and screens

Find the best dividend stocksShow peers with best dividend

CENIT AG

FRA:CSH (2/18/2026, 7:00:00 PM)

6.6

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06
Earnings (Next)04-09
Inst Owners47.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.24M
Revenue(TTM)210.10M
Net Income(TTM)-4.64M
Analysts90
Price Target13.52 (104.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.63%
PT rev (3m)-5.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.68
P/S 0.26
P/FCF 4.85
P/OCF 4.24
P/B 1.49
P/tB N/A
EV/EBITDA 6.45
EPS(TTM)-0.55
EYN/A
EPS(NY)0.14
Fwd EY2.14%
FCF(TTM)1.36
FCFY20.63%
OCF(TTM)1.56
OCFY23.57%
SpS25.1
BVpS4.43
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROCE 2.14%
ROIC 1.04%
ROICexc 1.35%
ROICexgc 9.09%
OM 0.91%
PM (TTM) N/A
GM 60.04%
FCFM 5.42%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexgc growth 3Y-6.55%
ROICexgc growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Debt/EBITDA 3.27
Cap/Depr 15.31%
Cap/Sales 0.77%
Interest Coverage 0.57
Cash Conversion 104.1%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.13
F-Score5
WACC6.89%
ROIC/WACC0.15
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%
EBIT growth 1Y-77.74%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year29.61%
EBIT Next 3Y44.31%
EBIT Next 5Y27.42%
FCF growth 1Y70.64%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y50.13%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%

CENIT AG / CSH.DE FAQ

What is the fundamental rating for CSH stock?

ChartMill assigns a fundamental rating of 3 / 10 to CSH.DE.


What is the valuation status of CENIT AG (CSH.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to CENIT AG (CSH.DE). This can be considered as Overvalued.


How profitable is CENIT AG (CSH.DE) stock?

CENIT AG (CSH.DE) has a profitability rating of 3 / 10.


What is the earnings growth outlook for CENIT AG?

The Earnings per Share (EPS) of CENIT AG (CSH.DE) is expected to decline by -228.95% in the next year.


Is the dividend of CENIT AG sustainable?

The dividend rating of CENIT AG (CSH.DE) is 6 / 10 and the dividend payout ratio is 0%.